Circulating 25-Hydroxyvitamin D and Prostate Cancer Survival.

  title={Circulating 25-Hydroxyvitamin D and Prostate Cancer Survival.},
  author={Alison M Mondul and Stephanie J Weinstein and Kristin A Moy and Satu M{\"a}nnist{\"o} and Demetrius Albanes},
  journal={Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology},
  volume={25 4},
BACKGROUND Recent epidemiologic evidence suggests that higher circulating vitamin D does not protect against prostate cancer and, in fact, may increase the risk of developing this malignancy. However, few studies have examined the most clinically relevant outcome, prostate cancer mortality. METHODS We examined prediagnostic serum 25-hydroxy-vitamin D (25(OH)D) and prostate cancer survival in a cohort of 1,000 cases in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study. During… CONTINUE READING
Highly Cited
This paper has 50 citations. REVIEW CITATIONS
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 15 extracted citations

51 Citations

Citations per Year
Semantic Scholar estimates that this publication has 51 citations based on the available data.

See our FAQ for additional information.


Publications referenced by this paper.
Showing 1-10 of 25 references

Genetic variation in the vitamin d pathway in relation to risk of prostate cancer – results from the breast and prostate cancer cohort consortium

  • BL Lokeshwar, GG Schwartz, MG Selzer, KL Burnstein, SH Zhuang, NL Block
  • Cancer Epidemiol Biomarkers Prev
  • 2013

Similar Papers

Loading similar papers…